Form D · Biotechnology
AMICUS THERAPEUTICS, INC.
Princeton, NJ · CIK 0001178879
Offering snapshot reported Oct 16, 2023 · SEC filing
- Reported sold
- $30M Offering amount: $30M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 5, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 16, 2023 | Initial | $29,999,985 | No comparison | 2 | SEC filing |
| Oct 13, 2021 | Initial | $199,916,500 | No comparison | 9 | SEC filing |
| Jul 19, 2016 | Initial | $4,706,000 | No comparison | 18 | SEC filing |
| Dec 3, 2013 | Initial | $15,000,000 | No comparison | 29 | SEC filing |
| Dec 3, 2013 | Initial | $15,000,000 | No comparison | 5 | SEC filing |
| Jul 30, 2012 | Initial | $18,582,360 | No comparison | 1 | SEC filing |
| Nov 5, 2010 | Initial | $31,284,583 | No comparison | 1 | SEC filing |
| May 25, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 28, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 30, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-494865
Source: Form D, filed Oct 16, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William D. Baird, Iii | Executive |
| Sol Barer | Director |
| Alexander E Barkas | Director |
| James Barrett | Director |
| Lynn D Bleil | Director |
| Pol F. Boudes | Executive |
| Bradley Campbell | Director, Executive |
| Jeffrey Castelli | Executive |
| Jeffrey P. Castelli, Ph.D. | Executive |
| David Clark | Executive |
| John F Crowley | Director |
| Enrique Dilone | Executive |
| Robert Essner | Director |
| Jayne Gerskowitz | Executive |
| Geoffrey P Gilmore | Executive |
| Simon Harford | Executive |
| Donald J Hayden | Director |
| Donald J. Hayden, Jr. | Director |
| Michael A Kelly | Director |
| John R. Kirk | Executive |
| David J. Lockhart | Executive |
| Ted W. Love | Director |
| Margaret G. Mc Glynn | Director |
| P Sherrill Neff | Director |
| Matthew R Patterson | Executive |
| Kenneth W. Peist | Executive |
| Samantha Prout | Executive |
| Daphne Quimi | Executive |
| Michael G Raab | Director |
| Eiry L. Roberts | Director |
| Eiry W Roberts, M.D. | Director |
| Ellen S. Rosenberg | Executive |
| Glen Sblendorio | Director |
| Glenn P Sblendorio | Director |
| S Nicole Schaeffer | Executive |
| James N. Topper | Director |
| Ken Valenzano | Executive |
| Craig A Wheeler | Director |
| Burke W Whitman | Director |
| Robert Winkler | Executive |
| Joan C. Winterbottom | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
47 Hulfish Street
Princeton, NJ, 08542
Princeton, NJ, 08542